Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability ; volume:84 ; number:3 ; day:14 ; month:3 ; year:2024 ; pages:285-304 ; date:3.2024
Drugs ; 84, Heft 3 (14.3.2024), 285-304, 3.2024
- Creator
-
Carlson, Alise K.
Amin, Moein
Cohen, Jeffrey A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40265-024-02011-w
- URN
-
urn:nbn:de:101:1-2406171043168.748985612202
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Carlson, Alise K.
- Amin, Moein
- Cohen, Jeffrey A.
- SpringerLink (Online service)
Other Objects (12)
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis
Direct, indirect and longitudinal immunological effects of anti-CD20 mediated B cell depletion in Multiple Sclerosis
Pharmakokinetik des monoklonalen anti-CD20 Antikörpers Rituximab bei aggressiven CD20 positiven B-Zell-Lymphomen
Pharmacology
Pharmacology
Pharmacology
The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis
Direct, indirect and longitudinal immunological effects of anti-CD20 mediated B cell depletion in Multiple Sclerosis
Pharmakokinetik des monoklonalen anti-CD20 Antikörpers Rituximab bei aggressiven CD20 positiven B-Zell-Lymphomen
Pharmacology
Pharmacology
Pharmacology
The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis
Direct, indirect and longitudinal immunological effects of anti-CD20 mediated B cell depletion in Multiple Sclerosis
Pharmakokinetik des monoklonalen anti-CD20 Antikörpers Rituximab bei aggressiven CD20 positiven B-Zell-Lymphomen
Pharmacology
Pharmacology
Pharmacology
The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis